Header Logo

Connection

Haseena Cassim to Tablets

Back to Details
This is a "connection" page, showing publications Haseena Cassim has written about Tablets.
Haseena Cassim
Connection Strength
0,055
Tablets
  1. Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study. Lancet HIV. 2023 08; 10(8):e506-e517.
    View in: PubMed
    Score: 0,055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.